A Striking Surge in Cases

Public health officials in Maryland are closely monitoring what has become a dramatic increase in mumps infections. As of mid-February 2026, the state has documented 26 cases of mumps, comprising 19 confirmed and 7 probable cases. To put that number in perspective, the entire state recorded only four mumps cases throughout all of 2025, meaning the current figure represents more than a sixfold increase in a fraction of the time.

The concentration of cases in the Baltimore metropolitan area has prompted local and state health departments to investigate whether the infections are epidemiologically linked. While the specific cause of the surge remains under active investigation, the numbers have drawn attention from public health experts across the region and raised questions about mumps vulnerability even in well-vaccinated populations.

Mumps in a Vaccinated Population

Perhaps the most notable aspect of the Maryland outbreak is that the majority of infected individuals had previously received the measles-mumps-rubella (MMR) vaccine. This detail, while concerning at first glance, aligns with what scientists have long known about the vaccine's effectiveness against mumps specifically.

The MMR vaccine is approximately 85 percent effective against mumps when both recommended doses have been administered. While this level of protection is substantial, it means that roughly one in seven fully vaccinated individuals remains susceptible to infection. In contrast, the same vaccine provides approximately 97 percent protection against measles and 97 percent protection against rubella.

This effectiveness gap is not a new revelation, but it becomes highly visible during outbreaks. When mumps circulates in environments where people have close, prolonged contact, even vaccinated individuals can contract and transmit the virus. College campuses, sports teams, and workplaces have historically been common settings for mumps outbreaks in vaccinated populations.